Nuvation Bio Inc. (NUVB) Misses Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts NUVB Hot Sheet
Join SI Premium – FREE
Nuvation Bio Inc. (NYSE: NUVB) reported Q4 EPS of ($0.15), $0.01 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $5.71 million versus the consensus estimate of $0 .
For earnings history and earnings-related data on Nuvation Bio Inc. (NUVB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Btig warns stock investors on seasonal weakness ahead in election year
- INVO Fertility (IVF) Tops Q2 EPS by 105c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
